The pandemic has caused the cancellations and delays of clinical trials, making it ever more challenging to effectively plan, design and execute clinical trials, especially for emerging companies.
The Covid pandemic has certainly forced us to re-think the whole paradigm of conducting clinical trials. From design, site and CRO selection, patient recruitment, data management, to execution, the world of clinical trials has been altered significantly in 2020…and most likely beyond.
Please join us for a free webinar series featuring leaders from industry and academia to introduce latest research, technologies, and tools. Speaker: Siva Chavadi, Ph.D., Senior Field Application Scientist, New [….]
AWIS Baltimore is excited to announce “B’More Women in STEM vs. COVID-19- Round II”, a continuation of our virtual series highlight important COVID-19 research done by Baltimore Women in STEM! [….]
Today’s biotech market is extremely competitive and riddled with difficult career-growth obstacles. Some are within our control, others that are not. More than ever, networking and relationships dictate career success. [….]
Join us for a lively discussion between our region’s top innovators and connectors to hear about their efforts to help grow the innovation ecosystem and the pipeline of successful startups across the BioHealth Capital Region.
The Small Business Innovation Research (SBIR) is one of the largest sources of early-stage capital for technology commercialization in the United States. NIH’s SBIR program invests over 1 billion dollars [….]
VCs Cautious of “COVID-19 Contortionists” and Telemedicine “Gold Rush” COVID-19 is fundamentally changing how we live, how we do business, and how we approach and deliver our healthcare. In the [….]
The Art of Negotiating Compensation With Maura Kahn and Kunal Chadha Written by: Katrina Adlerz Negotiating compensation with a potential future employer or with a current employer may appear to [….]
I know what you’re thinking…it’s hard enough to raise venture capital for life science/healthcare startups in normal times, but throw a global pandemic and economic meltdown into the mix and [….]
